• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[卵巢癌改良后盆腔脏器清除术后的术后并发症]

[Postoperative morbidities after modified posterior pelvic exenteration for ovarian cancer].

作者信息

Emin L, Meeus P, Beurrier F, Ferraioli D, Carrabin N, Ray-Coquard I, Treilleux I, Chopin N

机构信息

Département de chirurgie oncologique, centre de lutte contre le cancer Lyon et Rhône-Alpes, 28, rue Laennec, 69373 Lyon cedex 08, France.

Département de chirurgie oncologique, centre de lutte contre le cancer Lyon et Rhône-Alpes, 28, rue Laennec, 69373 Lyon cedex 08, France.

出版信息

Gynecol Obstet Fertil. 2015 May;43(5):342-7. doi: 10.1016/j.gyobfe.2015.03.006. Epub 2015 Apr 18.

DOI:10.1016/j.gyobfe.2015.03.006
PMID:25899113
Abstract

OBJECTIVE

Complication and survival analysis of cytoreduction surgery with modified posterior pelvic exenteration in the surgical treatment of the ovarian malignant tumor.

METHODS

A retrospective monocentric study between 2000 and 2013 in Rhone-Alpes cancer treatment center. One hundred and fifty-two patients with ovarian cancer and treated by surgery with modified posterior pelvic exenteration were included. Complication in the 30 days after surgery was analysed by the Clavien-Dindo classification.

RESULTS

In our study, rate of global complication was 62.5% with a morbidity rate of grave complication of 7.9%. Our rate of complete resection was 82.2%. Three fistulas (2.2%) were found. On average, there was 6.6±1.8 (2-11) surgery gesture associated with Hudson resection during surgery. In univariate analysis, there was a statistic significant association between complication from the rank II of Clavien-Dindo classification and supraradical surgery, post-chemotherapy surgery, recurrent surgery, the resection of a diaphragmatic dome, and the partial gastric resection. This association was also observed with the number of surgical gesture associated with Hudson resection.

CONCLUSIONS

The main prognostic surgical factor in ovarian cancer is to obtain a no macroscopic residual disease. The modified posterior pelvic exenteration allowed to obtain it. Our study demonstrates a low rate of grave complication further to this type of surgery.

摘要

目的

分析改良后盆腔脏器清除术在卵巢恶性肿瘤手术治疗中的并发症及生存情况。

方法

对2000年至2013年在罗纳-阿尔卑斯癌症治疗中心进行的一项回顾性单中心研究。纳入152例行改良后盆腔脏器清除术治疗的卵巢癌患者。采用Clavien-Dindo分类法分析术后30天内的并发症。

结果

在我们的研究中,总体并发症发生率为62.5%,严重并发症发生率为7.9%。完全切除率为82.2%。发现3例瘘(2.2%)。手术中与哈德逊切除术相关的平均手术操作次数为6.6±1.8(2 - 11次)。单因素分析显示,Clavien-Dindo分类Ⅱ级并发症与超根治性手术、化疗后手术、复发性手术、膈肌穹窿切除及部分胃切除之间存在统计学显著关联。这种关联在与哈德逊切除术相关的手术操作次数上也有体现。

结论

卵巢癌手术的主要预后因素是实现无肉眼可见残留病灶。改良后盆腔脏器清除术能够实现这一点。我们的研究表明,此类手术后严重并发症发生率较低。

相似文献

1
[Postoperative morbidities after modified posterior pelvic exenteration for ovarian cancer].[卵巢癌改良后盆腔脏器清除术后的术后并发症]
Gynecol Obstet Fertil. 2015 May;43(5):342-7. doi: 10.1016/j.gyobfe.2015.03.006. Epub 2015 Apr 18.
2
Modified posterior pelvic exenteration for advanced ovarian malignancies: a single-institution study of 35 cases.
Acta Obstet Gynecol Scand. 2017 Sep;96(9):1136-1143. doi: 10.1111/aogs.13177. Epub 2017 Jul 6.
3
Posterior pelvic exenteration and retrograde total hysterectomy in patients with locally advanced ovarian cancer: Clinical and functional outcome.局部晚期卵巢癌患者的后盆腔脏器清除术及逆行全子宫切除术:临床及功能结局
Taiwan J Obstet Gynecol. 2016 Jun;55(3):346-50. doi: 10.1016/j.tjog.2016.04.010.
4
Modified posterior exenteration for ovarian cancer.卵巢癌改良后盆腔脏器清除术
Obstet Gynecol. 1991 Nov;78(5 Pt 1):879-85.
5
Histopathologic tumor spreading in primary ovarian cancer with modified posterior exenteration.原发性卵巢癌伴改良后盆腔脏器清除术的组织病理学肿瘤播散
World J Surg Oncol. 2015 Jul 31;13:230. doi: 10.1186/s12957-015-0647-x.
6
Comparison of morbidity and survival between primary and interval cytoreductive surgery in patients after modified posterior pelvic exenteration for advanced ovarian cancer.改良后的后盆腔切除术治疗晚期卵巢癌患者的初次和间隔减瘤术后发病率和生存情况比较。
Int J Gynecol Cancer. 2012 Oct;22(8):1349-54. doi: 10.1097/IGC.0b013e318265d358.
7
Modified posterior pelvic exenteration for ovarian cancer.改良后盆腔脏器清除术治疗卵巢癌
Int J Gynecol Cancer. 2009 Jul;19(5):968-73. doi: 10.1111/IGC.0b013e3181a7f38b.
8
Modified posterior pelvic exenteration with pelvic side-wall resection requiring both intestinal and urinary reconstruction during surgery for ovarian cancer.用于卵巢癌治疗的改良式盆腔后切除术,需要在手术中同时进行肠和尿路重建,以切除骨盆侧壁。
Gynecol Oncol. 2019 Oct;155(1):172-173. doi: 10.1016/j.ygyno.2019.07.015. Epub 2019 Jul 25.
9
Predictors of postoperative morbidity after cytoreduction for advanced ovarian cancer: Analysis and management of complications in upper abdominal surgery.高级卵巢癌细胞减灭术后术后发病率的预测因素:上腹部手术并发症的分析与处理。
Gynecol Oncol. 2015 Jun;137(3):406-11. doi: 10.1016/j.ygyno.2015.03.043. Epub 2015 Mar 28.
10
[Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].[伴有泌尿系统侵犯的直肠癌盆腔脏器清除术的泌尿系统并发症]
Prog Urol. 2015 May;25(6):348-54. doi: 10.1016/j.purol.2015.02.005. Epub 2015 Mar 21.

引用本文的文献

1
The value of transitory protective stomas during primary debulking surgery for advanced epithelial ovarian cancer: a retrospective cohort study.暂时性保护性造口在晚期上皮性卵巢癌初次肿瘤细胞减灭术中的价值:一项回顾性队列研究
Int J Surg. 2024 Nov 1;110(11):6922-6932. doi: 10.1097/JS9.0000000000001474.
2
Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis.保护性造口术在卵巢癌手术中的应用:系统评价和荟萃分析。
J Gynecol Oncol. 2022 Mar;33(2):e21. doi: 10.3802/jgo.2022.33.e21.